Advertisement

Topics

ASPREE: No Benefit of Aspirin in Primary Prevention

09:39 EDT 16 Sep 2018 | Medscape

Findings of the ASPREE trial show no benefit, at all, of aspirin in primary prevention of disability, cardiovascular events and death, or all-cause death in healthy elderly people.
Medscape Medical News

Original Article: ASPREE: No Benefit of Aspirin in Primary Prevention

NEXT ARTICLE

More From BioPortfolio on "ASPREE: No Benefit of Aspirin in Primary Prevention"

Advertisement
Quick Search
Advertisement
Advertisement